Neoplasms, Germ Cell and Embryonal clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
LY4336619 in Adult Participants With Advanced Solid Tumors
Sorry, not yet accepting patients
The main purpose of this study is to evaluate how safe and effective LY4336619 is in adults with advanced cancer. Some participants will receive LY4336619 alone, and some will receive it with another cancer medicine. Participants will be in the study for up to 2 years, depending on how they tolerate and respond to treatment.
at UCSD
Last updated: